Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Generation Bio (GBIO) Common Equity (2021 - 2025)

Historic Common Equity for Generation Bio (GBIO) over the last 5 years, with Q3 2025 value amounting to $50.6 million.

  • Generation Bio's Common Equity fell 5159.04% to $50.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $50.6 million, marking a year-over-year decrease of 5159.04%. This contributed to the annual value of $86.2 million for FY2024, which is 5756.17% down from last year.
  • Per Generation Bio's latest filing, its Common Equity stood at $50.6 million for Q3 2025, which was down 5159.04% from $54.1 million recorded in Q2 2025.
  • In the past 5 years, Generation Bio's Common Equity ranged from a high of $458.7 million in Q1 2021 and a low of $50.6 million during Q3 2025
  • Over the past 5 years, Generation Bio's median Common Equity value was $254.3 million (recorded in 2023), while the average stood at $238.7 million.
  • Per our database at Business Quant, Generation Bio's Common Equity crashed by 2090.48% in 2023 and then plummeted by 5756.17% in 2024.
  • Quarter analysis of 5 years shows Generation Bio's Common Equity stood at $381.7 million in 2021, then fell by 26.0% to $282.5 million in 2022, then dropped by 28.09% to $203.1 million in 2023, then tumbled by 57.56% to $86.2 million in 2024, then crashed by 41.35% to $50.6 million in 2025.
  • Its Common Equity was $50.6 million in Q3 2025, compared to $54.1 million in Q2 2025 and $73.3 million in Q1 2025.